Galectin Therapeutics (GALT) Other Non-Current Liabilities (2010 - 2026)
Galectin Therapeutics' Other Non-Current Liabilities came in at $59,000 for Q2 2026, down 96.2% from $1.54 million a year earlier and down 98.0% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics' Other Non-Current Liabilities was $3.96 million.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 245.9% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $47,000 in FY2024 (-95.3%), $1 million in FY2023 (+75.2%), $573,000 in FY2022 (-49.3%) and $1.13 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Liabilities since Q4 2024.
- Year-over-year, Other Non-Current Liabilities increased in 1 of the last five quarters, with an average decline of 47.2%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2024 (growth of 107.0%), and the weakest in Q2 2026 (a decline of 96.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Galectin Therapeutics | 222.99 Mn | 166.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,000.00 |
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 896,000.00 |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 639,000.00 |
| Sep 30, 2022 | 927,000.00 |
| Jun 30, 2022 | 713,000.00 |
| Mar 31, 2022 | 998,000.00 |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 592,000.00 |
API Access
Galectin Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();